Overall Technical outlook

Price Summary

On 2026-07-01, Gland Pharma Limited's stock began at 2495.0, climbed to 2504.1, dropped to 2425.0, and had -1.19% to end at 2465.2, with a volume of 541560 shares.
During the past 52 weeks, the highest stock price was 2495.0, and the lowest was 1596.8.

Technicals


Aroon: The AROON is in a neutral stance, with no clear signals for movement up or down. This neutral position indicates a potential period of consolidation or uncertainty in the market.
GLAND aroon 38ce76
Aroon chart for Gland Pharma Limited


Bol. Bands: The current price remains above the upper Bollinger Band, reflecting strong upward momentum for GLAND since its previous move. This could suggest that the asset is overbought, with traders possibly interpreting this as a sign of sustained strength. However, caution is warranted, as extended periods above the band could lead to a correction or reversal, marking a potential turning point in the trend.
GLAND bbands 38ce76
Bolinger Bands chart for Gland Pharma Limited


Parabolic SAR: The PSAR remains bullish in its outlook, establishing a key support level that could serve as a foundation for further upward movement. This persistent bullish stance suggests that the market may continue to trend higher, with the established support providing a potential safety net for investors.
GLAND psar 38ce76
Parabolic Stop and Reverse chart for Gland Pharma Limited


Stochastic: The stochastic indicator for Gland Pharma Limited reflects a bullish sentiment, as the K-line is above both the D-line and the 80 threshold. This setup points to strong upward momentum, implying that the market may continue to rise. Traders could consider this as an indication of sustained bullish activity.
GLAND stoch 38ce76
Stochastic chart for Gland Pharma Limited


Tripple Moving Agerage: The 20, 50, and 100 moving averages are aligned bearishly, signaling a downtrend. However, the slopes of the 20 and 50 SMAs are starting to waver, indicating that this bearish momentum might be losing strength. This could suggest an upcoming shift towards bullish price action, as the market's current downward trend may be approaching a reversal, potentially leading to a new upward move.
GLAND trippleSMA 38ce76
Tripple SMA chart for Gland Pharma Limited


When evaluating a company's technical data, such as stock price charts or volume, it is essential to first consider its fundamentals. These fundamentals include financial stability, growth potential, and competitive advantages. Additionally, understanding the broader industry in which the company operates offers context that helps to make sense of technical patterns. By examining both the company's internal strengths and external environment, one can make more accurate and meaningful conclusions about its stock performance.